Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05843890
Other study ID # HUM00214375
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 18, 2023
Est. completion date February 2025

Study information

Verified date August 2023
Source University of Michigan
Contact Beth Banner
Phone 734-998-5837
Email eledward@umich.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for chronic low back pain. This research will try to understand how much an electronic, self-management website like PainGuide can help participants. The study hypothesizes that tailored digital interventions (plus using PainGuide) will demonstrate greater improvement in pain interference.


Recruitment information / eligibility

Status Recruiting
Enrollment 430
Est. completion date February 2025
Est. primary completion date February 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Chronic Lower Back pain (cLBP) defined by the National Institutes of Health (NIH) Task Force Report on Research Standards for Chronic Low Back Pain, (i.e., low back pain present at least six months, and present more than half of those days.) - Individuals must have a score of greater or equal to (=) 60 on PROMIS Pain Interference. Exclusion Criteria: - Current cancer related pain - Diagnosis of autoimmune disease - Unable to speak, write or read English - Visual or hearing difficulties - Pregnancy or breastfeeding - Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Structured and tailored PainGuide
Participants will receive specific instruction to complete one module a week over the first 4 weeks. Participants will then receive tailored messaging using scores from the assessments completed during T1(baseline visit) from the PROMIS 29+2. Participants will be asked to complete surveys over 24 weeks. All participants will also be registered with a Fitbit device that is linked to the PainGuide to capture movement data (daily step counts).
Standard PainGuide
Participants in the control group will not receive any messaging once enrolled. Participants will be asked to complete surveys over 24 weeks. All participants will also be registered with a Fitbit device that is linked to the PainGuide to capture movement data (daily step counts).

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (1)

Lead Sponsor Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference score The PROMIS Pain Interference consists of 4-items that assess the degree to which pain interferes with various aspects of life. Items are scored on a 1 ("Not at all") to 5 ("Very much") scale with a range of 4 - 20. Higher scores indicate greater pain interference Baseline, Week 24
Secondary Change in pain intensity based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 There is one question that participants select 0 (no pain) - 10 (worst imaginable pain). Baseline, Week 24
Secondary Change in the Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive function There are 2 questions regarding cognitive function where participants select answers from not at all (1)-very mush (5) regarding cognitive function. There is a total of 10 points where higher scores mean higher cognitive function. Baseline, Week 24
Secondary Change in the physical function based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 There are 4 questions that participants will select from without any difficulty (5) to unable to do (1). There are a total of 20 points where higher scores indicate higher physical function. Baseline, Week 24
Secondary Change in anxiety based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 There are 4 questions that participants will select from never (1) to always (5). There are a total of 20 points where lower scores indicate lower levels of anxiety. Baseline, Week 24
Secondary Change in depression based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 There are 4 questions that participants will select from never (1) to always (5). There are a total of 20 points where higher scores indicate higher levels of depression. Baseline, Week 24
Secondary Change in fatigue based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 There are 4 questions that participants will select from not at all (1) to very much (5). There are a total of 20 points where higher scores indicate higher levels of fatigue. Baseline, Week 24
Secondary Change in sleep disturbance based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 There are 4 questions that participants will select from. Question 1 participants will select from Very poor (5) to very good. Questions 2-4 participants will select from not all (5) to very much (1). There are a total of 20 points where higher scores indicate higher sleep disturbances. Baseline, Week 24
Secondary Change in ability to participate in social roles and activities based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 There are 4 questions that participants will select from never (5) to always (1). There are a total of 20 points where lower scores indicate more difficulty participating in social roles. Baseline, Week 24
Secondary Change in pain interference based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 There are 4 questions that participants will select from not at all (1) to very much (5). There are a total of 20 points where lower scores indicate less pain interference. Baseline, Week 24
See also
  Status Clinical Trial Phase
Completed NCT04409353 - Virtual Reality Therapy for Chronic Low Back Pain N/A
Completed NCT02946073 - Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain Phase 3
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Recruiting NCT01765777 - Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain N/A
Completed NCT04156802 - Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain N/A
Enrolling by invitation NCT02529566 - Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine N/A
Completed NCT01894282 - Mind Body Intervention for Chronic Lower Back Pain Phase 3
Completed NCT02157389 - Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain N/A
Recruiting NCT06282770 - Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery N/A
Completed NCT04415177 - Virtual Reality Trial Using EaseVRx For Chronic Low Back Pain N/A
Completed NCT05894213 - Prevalence and Factors Associated With Sarcopenia in Pre-retirement Aged Adults With Chronic Non-specific Lower Back Pain
Recruiting NCT02241824 - Chronic Opioid Use in Low Back Pain and Lumbar Orthosis Intervention N/A
Completed NCT02611466 - A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee Phase 2
Completed NCT03049644 - A Trial Comparing Mechanical Diagnosis and Treatment to Manual Therapy N/A
Recruiting NCT02539979 - A Trial of Intravenous Paracetamol vs. Placebo in Patients Receiving Radiofrequency Ablation of the Medial Branch Facet Nerve N/A